Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christopher L King

Showing results (91-100 of 178) with videos related to

Pageof 18
Sort By:
Plos Neglected Tropical Diseases|October 24, 2018
Update on the current status of onchocerciasis in Côte d'Ivoire following 40 years of intervention: Progress and challengesBenjamin G Koudou, Marie-Madeleine Kouakou, Allassane F Ouattara, et al.
Plos Neglected Tropical Diseases|June 1, 2023
Population pharmacokinetic model of ivermectin in mass drug administration against lymphatic filariasisAbdullah Alshehri, Yashpal S Chhonker, Veenu Bala, et al.
Plos Neglected Tropical Diseases|December 3, 2025
Semi-annual and annual mass drug administration of diethylcarbamazine and albendazole are equally effective regimens for eliminating lymphatic filariasis in Papua New GuineaMichael C Payne, Nelly Sanuku, Brooke E Mancuso, et al.
Plos Neglected Tropical Diseases|May 21, 2019
Pharmacokinetics, safety, and efficacy of a single co-administered dose of diethylcarbamazine, albendazole and ivermectin in adults with and without Wuchereria bancrofti infection in Côte d'IvoireConstant Edi, Catherine M Bjerum, Allassane F Ouattara, et al.
Transactions of the Royal Society of Tropical Medicine and Hygiene|March 12, 2015
Risk factors for malaria and adverse birth outcomes in a prospective cohort of pregnant women resident in a high malaria transmission area of Papua New GuineaDanielle I Stanisic, Kerryn A Moore, Francesca Baiwog, et al.
Plos Neglected Tropical Diseases|September 18, 2023
Safety and tolerability of moxidectin and ivermectin combination treatments for lymphatic filariasis in Côte d'Ivoire: A randomized controlled superiority studyCatherine M Bjerum, Benjamin G Koudou, Allassane F Ouattara, et al.
The New England Journal of Medicine|November 8, 2018
A Trial of a Triple-Drug Treatment for Lymphatic FilariasisChristopher L King, James Suamani, Nelly Sanuku, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|March 6, 2021
Semiannual Treatment of Albendazole Alone is Efficacious for Treatment of Lymphatic Filariasis: A Randomized Open-label Trial in Cote d'IvoireAllassane F Ouattara, Catherine M Bjerum, Méité Aboulaye, et al.
Open Forum Infectious Diseases|March 2, 2023
Association of Cytomegalovirus Serostatus With Severe Acute Respiratory Syndrome Coronavirus 2 Vaccine Responsiveness in Nursing Home Residents and Healthcare WorkersMichael L Freeman, Oladayo A Oyebanji, Daniela Moisi, et al.
The Journal of Infectious Diseases|August 5, 2015
Impact of Placental Malaria and Hypergammaglobulinemia on Transplacental Transfer of Respiratory Syncytial Virus Antibody in Papua New GuineaJessica E Atwell, Bhagvanji Thumar, Leanne J Robinson, et al.
Pageof 18

Showing results (91-100 of 178) with videos related to

Sort By:
Pageof 18
Plos Neglected Tropical Diseases|October 24, 2018
Update on the current status of onchocerciasis in Côte d'Ivoire following 40 years of intervention: Progress and challengesBenjamin G Koudou, Marie-Madeleine Kouakou, Allassane F Ouattara, et al.
Plos Neglected Tropical Diseases|June 1, 2023
Population pharmacokinetic model of ivermectin in mass drug administration against lymphatic filariasisAbdullah Alshehri, Yashpal S Chhonker, Veenu Bala, et al.
Plos Neglected Tropical Diseases|December 3, 2025
Semi-annual and annual mass drug administration of diethylcarbamazine and albendazole are equally effective regimens for eliminating lymphatic filariasis in Papua New GuineaMichael C Payne, Nelly Sanuku, Brooke E Mancuso, et al.
Plos Neglected Tropical Diseases|May 21, 2019
Pharmacokinetics, safety, and efficacy of a single co-administered dose of diethylcarbamazine, albendazole and ivermectin in adults with and without Wuchereria bancrofti infection in Côte d'IvoireConstant Edi, Catherine M Bjerum, Allassane F Ouattara, et al.
Transactions of the Royal Society of Tropical Medicine and Hygiene|March 12, 2015
Risk factors for malaria and adverse birth outcomes in a prospective cohort of pregnant women resident in a high malaria transmission area of Papua New GuineaDanielle I Stanisic, Kerryn A Moore, Francesca Baiwog, et al.
Plos Neglected Tropical Diseases|September 18, 2023
Safety and tolerability of moxidectin and ivermectin combination treatments for lymphatic filariasis in Côte d'Ivoire: A randomized controlled superiority studyCatherine M Bjerum, Benjamin G Koudou, Allassane F Ouattara, et al.
The New England Journal of Medicine|November 8, 2018
A Trial of a Triple-Drug Treatment for Lymphatic FilariasisChristopher L King, James Suamani, Nelly Sanuku, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|March 6, 2021
Semiannual Treatment of Albendazole Alone is Efficacious for Treatment of Lymphatic Filariasis: A Randomized Open-label Trial in Cote d'IvoireAllassane F Ouattara, Catherine M Bjerum, Méité Aboulaye, et al.
Open Forum Infectious Diseases|March 2, 2023
Association of Cytomegalovirus Serostatus With Severe Acute Respiratory Syndrome Coronavirus 2 Vaccine Responsiveness in Nursing Home Residents and Healthcare WorkersMichael L Freeman, Oladayo A Oyebanji, Daniela Moisi, et al.
The Journal of Infectious Diseases|August 5, 2015
Impact of Placental Malaria and Hypergammaglobulinemia on Transplacental Transfer of Respiratory Syncytial Virus Antibody in Papua New GuineaJessica E Atwell, Bhagvanji Thumar, Leanne J Robinson, et al.
Pageof 18